These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Neuropeptide CGRP Limits Group 2 Innate Lymphoid Cell Responses and Constrains Type 2 Inflammation. Nagashima H; Mahlakõiv T; Shih HY; Davis FP; Meylan F; Huang Y; Harrison OJ; Yao C; Mikami Y; Urban JF; Caron KM; Belkaid Y; Kanno Y; Artis D; O'Shea JJ Immunity; 2019 Oct; 51(4):682-695.e6. PubMed ID: 31353223 [TBL] [Abstract][Full Text] [Related]
4. Calcitonin Gene-Related peptide receptor antagonist suppresses allergic asthma responses via downregulation of group 2 innate lymphoid cells in mice. Ike E; Kawano T; Takahashi K; Miyasaka T; Takahashi T Int Immunopharmacol; 2023 Sep; 122():110608. PubMed ID: 37441811 [TBL] [Abstract][Full Text] [Related]
5. Mediation of the JNC/ILC2 pathway in DBP-exacerbated allergic asthma: A molecular toxicological study on neuroimmune positive feedback mechanism. Xie X; Li Y; Yan B; Peng Q; Yao R; Deng Q; Li J; Wu Y; Chen S; Yang X; Ma P J Hazard Mater; 2024 Mar; 465():133360. PubMed ID: 38157815 [TBL] [Abstract][Full Text] [Related]
6. The neuropeptide neuromedin U stimulates innate lymphoid cells and type 2 inflammation. Klose CSN; Mahlakõiv T; Moeller JB; Rankin LC; Flamar AL; Kabata H; Monticelli LA; Moriyama S; Putzel GG; Rakhilin N; Shen X; Kostenis E; König GM; Senda T; Carpenter D; Farber DL; Artis D Nature; 2017 Sep; 549(7671):282-286. PubMed ID: 28869965 [TBL] [Abstract][Full Text] [Related]
7. Activation of group 2 innate lymphoid cells exacerbates and confers corticosteroid resistance to mouse nasal type 2 inflammation. Morikawa T; Fukuoka A; Matsushita K; Yasuda K; Iwasaki N; Akasaki S; Fujieda S; Yoshimoto T Int Immunol; 2017 May; 29(5):221-233. PubMed ID: 28541554 [TBL] [Abstract][Full Text] [Related]
8. Respiratory syncytial virus prevents the subsequent development of ovalbumin-induced allergic responses by inhibiting ILC2 via the IL-33/ST2 pathway. Wang D; Bai S; Cui Y; Zhao N; Qi F; Liu J; Zeng S; Xu L; Hu H; Liu B Immunotherapy; 2018 Sep; 10(12):1065-1076. PubMed ID: 30027786 [TBL] [Abstract][Full Text] [Related]
10. Targeting androgen signaling in ILC2s protects from IL-33-driven lung inflammation, independently of KLRG1. Blanquart E; Mandonnet A; Mars M; Cenac C; Anesi N; Mercier P; Audouard C; Roga S; Serrano de Almeida G; Bevan CL; Girard JP; Pelletier L; Laffont S; Guéry JC J Allergy Clin Immunol; 2022 Jan; 149(1):237-251.e12. PubMed ID: 33964300 [TBL] [Abstract][Full Text] [Related]
11. Pulmonary innate lymphoid cells are major producers of IL-5 and IL-13 in murine models of allergic asthma. Klein Wolterink RG; Kleinjan A; van Nimwegen M; Bergen I; de Bruijn M; Levani Y; Hendriks RW Eur J Immunol; 2012 May; 42(5):1106-16. PubMed ID: 22539286 [TBL] [Abstract][Full Text] [Related]
12. Th2 cell-derived IL-4/IL-13 promote ILC2 accumulation in the lung by ILC2-intrinsic STAT6 signaling in mice. Symowski C; Voehringer D Eur J Immunol; 2019 Sep; 49(9):1421-1432. PubMed ID: 31144294 [TBL] [Abstract][Full Text] [Related]
13. The neuropeptide calcitonin gene-related peptide affects allergic airway inflammation by modulating dendritic cell function. Rochlitzer S; Veres TZ; Kühne K; Prenzler F; Pilzner C; Knothe S; Winkler C; Lauenstein HD; Willart M; Hammad H; Müller M; Krug N; Lambrecht BN; Braun A Clin Exp Allergy; 2011 Nov; 41(11):1609-21. PubMed ID: 21752117 [TBL] [Abstract][Full Text] [Related]
14. Collaborative interactions between type 2 innate lymphoid cells and antigen-specific CD4+ Th2 cells exacerbate murine allergic airway diseases with prominent eosinophilia. Liu B; Lee JB; Chen CY; Hershey GK; Wang YH J Immunol; 2015 Apr; 194(8):3583-93. PubMed ID: 25780046 [TBL] [Abstract][Full Text] [Related]
15. T cells and ILC2s are major effector cells in influenza-induced exacerbation of allergic airway inflammation in mice. Li BWS; de Bruijn MJW; Lukkes M; van Nimwegen M; Bergen IM; KleinJan A; GeurtsvanKessel CH; Andeweg A; Rimmelzwaan GF; Hendriks RW Eur J Immunol; 2019 Jan; 49(1):144-156. PubMed ID: 29762870 [TBL] [Abstract][Full Text] [Related]
16. CD4 Lin L; Chen Z; Dai F; Wei JJ; Tang XY; Sun GB Auris Nasus Larynx; 2019 Aug; 46(4):533-541. PubMed ID: 30554982 [TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of ILC2s in the Intestine; Homeostasis and Pathology. Sunaga S; Tsunoda J; Teratani T; Mikami Y; Kanai T Front Immunol; 2022; 13():867351. PubMed ID: 35707544 [TBL] [Abstract][Full Text] [Related]
18. Systemic administration of IL-33 induces a population of circulating KLRG1 Guillerey C; Stannard K; Chen J; Krumeich S; Miles K; Nakamura K; Smith J; Yu Y; Ng S; Harjunpää H; Teng MW; Engwerda C; Belz GT; Smyth MJ Immunol Cell Biol; 2021 Jan; 99(1):65-83. PubMed ID: 32748462 [TBL] [Abstract][Full Text] [Related]
19. Group 2 innate lymphoid cells facilitate sensitization to local, but not systemic, TH2-inducing allergen exposures. Gold MJ; Antignano F; Halim TY; Hirota JA; Blanchet MR; Zaph C; Takei F; McNagny KM J Allergy Clin Immunol; 2014 Apr; 133(4):1142-8. PubMed ID: 24679471 [TBL] [Abstract][Full Text] [Related]
20. ICOS regulates the pool of group 2 innate lymphoid cells under homeostatic and inflammatory conditions in mice. Paclik D; Stehle C; Lahmann A; Hutloff A; Romagnani C Eur J Immunol; 2015 Oct; 45(10):2766-72. PubMed ID: 26249010 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]